{"transactions":[{"id":760696,"issuer":{"id":7071,"kind":"organization","name":"Rein Therapeutics, Inc."},"owners":[{"id":43624,"kind":"person","name":"VON RICKENBACH JOSEF H","position":1,"cik":"0001007706","reported_name":"VON RICKENBACH JOSEF H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock , $0.001 par value","published_at":"2026-05-29T00:15:59.000Z","date":"2026-05-27","kind":"purchase","planned":false,"acquired":true,"shares":4500,"price":1.0708,"value":4818.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported shares were purchased in the open market in multiple transactions at prices ranging from $1.05 and $1.035 on May 21, 2026, $1.07 and $1.01 on May 22, 2026, $1.07 and $1.03 on May 26, 2026 and $1.08 and $1.03 on May 27, 2026.  The prices reported in Column 4 are a weighted average price for purchase on the respective day. The reporting person undertakes to provide to Rein Therapeutics, Inc., any stockholder of Rein Therapeutics, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (1)."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The reported shares were purchased in the open market in multiple transactions at prices ranging from $1.05 and $1.035 on May 21, 2026, $1.07 and $1.01 on May 22, 2026, $1.07 and $1.03 on May 26, 2026 and $1.08 and $1.03 on May 27, 2026.  The prices reported in Column 4 are a weighted average price for purchase on the respective day. The reporting person undertakes to provide to Rein Therapeutics, Inc., any stockholder of Rein Therapeutics, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (1)."}],"balance_after":62514,"source":{"system":"sec-edgar","filing":"0001193125-26-245832","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1007706/000119312526245832/ownership.xml","form_type":"4"}},{"id":760695,"issuer":{"id":7071,"kind":"organization","name":"Rein Therapeutics, Inc."},"owners":[{"id":43624,"kind":"person","name":"VON RICKENBACH JOSEF H","position":1,"cik":"0001007706","reported_name":"VON RICKENBACH JOSEF H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock , $0.001 par value","published_at":"2026-05-29T00:15:59.000Z","date":"2026-05-26","kind":"purchase","planned":false,"acquired":true,"shares":23190,"price":1.0552,"value":24470.088,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported shares were purchased in the open market in multiple transactions at prices ranging from $1.05 and $1.035 on May 21, 2026, $1.07 and $1.01 on May 22, 2026, $1.07 and $1.03 on May 26, 2026 and $1.08 and $1.03 on May 27, 2026.  The prices reported in Column 4 are a weighted average price for purchase on the respective day. The reporting person undertakes to provide to Rein Therapeutics, Inc., any stockholder of Rein Therapeutics, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (1)."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The reported shares were purchased in the open market in multiple transactions at prices ranging from $1.05 and $1.035 on May 21, 2026, $1.07 and $1.01 on May 22, 2026, $1.07 and $1.03 on May 26, 2026 and $1.08 and $1.03 on May 27, 2026.  The prices reported in Column 4 are a weighted average price for purchase on the respective day. The reporting person undertakes to provide to Rein Therapeutics, Inc., any stockholder of Rein Therapeutics, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (1)."}],"balance_after":58014,"source":{"system":"sec-edgar","filing":"0001193125-26-245832","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1007706/000119312526245832/ownership.xml","form_type":"4"}},{"id":760694,"issuer":{"id":7071,"kind":"organization","name":"Rein Therapeutics, Inc."},"owners":[{"id":43624,"kind":"person","name":"VON RICKENBACH JOSEF H","position":1,"cik":"0001007706","reported_name":"VON RICKENBACH JOSEF H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock , $0.001 par value","published_at":"2026-05-29T00:15:59.000Z","date":"2026-05-22","kind":"purchase","planned":false,"acquired":true,"shares":15950,"price":1.0475,"value":16707.625,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported shares were purchased in the open market in multiple transactions at prices ranging from $1.05 and $1.035 on May 21, 2026, $1.07 and $1.01 on May 22, 2026, $1.07 and $1.03 on May 26, 2026 and $1.08 and $1.03 on May 27, 2026.  The prices reported in Column 4 are a weighted average price for purchase on the respective day. The reporting person undertakes to provide to Rein Therapeutics, Inc., any stockholder of Rein Therapeutics, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (1)."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The reported shares were purchased in the open market in multiple transactions at prices ranging from $1.05 and $1.035 on May 21, 2026, $1.07 and $1.01 on May 22, 2026, $1.07 and $1.03 on May 26, 2026 and $1.08 and $1.03 on May 27, 2026.  The prices reported in Column 4 are a weighted average price for purchase on the respective day. The reporting person undertakes to provide to Rein Therapeutics, Inc., any stockholder of Rein Therapeutics, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (1)."}],"balance_after":34824,"source":{"system":"sec-edgar","filing":"0001193125-26-245832","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1007706/000119312526245832/ownership.xml","form_type":"4"}},{"id":760693,"issuer":{"id":7071,"kind":"organization","name":"Rein Therapeutics, Inc."},"owners":[{"id":43624,"kind":"person","name":"VON RICKENBACH JOSEF H","position":1,"cik":"0001007706","reported_name":"VON RICKENBACH JOSEF H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock , $0.001 par value","published_at":"2026-05-29T00:15:59.000Z","date":"2026-05-21","kind":"purchase","planned":false,"acquired":true,"shares":3420,"price":1.0422,"value":3564.324,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The reported shares were purchased in the open market in multiple transactions at prices ranging from $1.05 and $1.035 on May 21, 2026, $1.07 and $1.01 on May 22, 2026, $1.07 and $1.03 on May 26, 2026 and $1.08 and $1.03 on May 27, 2026.  The prices reported in Column 4 are a weighted average price for purchase on the respective day. The reporting person undertakes to provide to Rein Therapeutics, Inc., any stockholder of Rein Therapeutics, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (1)."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The reported shares were purchased in the open market in multiple transactions at prices ranging from $1.05 and $1.035 on May 21, 2026, $1.07 and $1.01 on May 22, 2026, $1.07 and $1.03 on May 26, 2026 and $1.08 and $1.03 on May 27, 2026.  The prices reported in Column 4 are a weighted average price for purchase on the respective day. The reporting person undertakes to provide to Rein Therapeutics, Inc., any stockholder of Rein Therapeutics, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (1)."}],"balance_after":18874,"source":{"system":"sec-edgar","filing":"0001193125-26-245832","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1007706/000119312526245832/ownership.xml","form_type":"4"}},{"id":1083029,"issuer":{"id":7071,"kind":"organization","name":"Rein Therapeutics, Inc."},"owners":[{"id":43624,"kind":"person","name":"VON RICKENBACH JOSEF H","position":1,"cik":"0001007706","reported_name":"VON RICKENBACH JOSEF H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-07-23T23:40:12.000Z","date":"2025-07-23","kind":"grant","planned":false,"acquired":true,"shares":17500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on July 23, 2025. The shares underlying the option are scheduled to vest in full on the earlier of (i) July 23, 2026 or (ii) the date of the Issuer's 2026 Annual Meeting of Stockholders, subject to continued service."}],"balance_after":17500,"derivative":{"exercise_price":1.55,"expiration_date":"2035-07-22","underlying":"Common Stock","underlying_shares":17500},"source":{"system":"sec-edgar","filing":"0000950170-25-098044","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1007706/000095017025098044/ownership.xml","form_type":"4"}},{"id":1340946,"issuer":{"id":7071,"kind":"organization","name":"Rein Therapeutics, Inc."},"owners":[{"id":43624,"kind":"person","name":"VON RICKENBACH JOSEF H","position":1,"cik":"0001007706","reported_name":"VON RICKENBACH JOSEF H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-12-06T21:34:58.000Z","date":"2024-12-02","kind":"grant","planned":false,"acquired":true,"shares":35000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on December 2, 2024. The shares underlying the option are scheduled to vest in full on December 2, 2025."}],"balance_after":35000,"derivative":{"exercise_price":2.85,"expiration_date":"2034-12-01","underlying":"Common Stock","underlying_shares":35000},"source":{"system":"sec-edgar","filing":"0000950170-24-134152","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1007706/000095017024134152/ownership.xml","form_type":"4"}},{"id":1425895,"issuer":{"id":7071,"kind":"organization","name":"Rein Therapeutics, Inc."},"owners":[{"id":43624,"kind":"person","name":"VON RICKENBACH JOSEF H","position":1,"cik":"0001007706","reported_name":"VON RICKENBACH JOSEF H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-08-22T20:07:24.000Z","date":"2024-08-20","kind":"grant","planned":false,"acquired":true,"shares":2725,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on August 20, 2024. The shares underlying the option are scheduled to vest in full on the earlier of (i) August 20, 2025 or (ii) the date of the Issuer's 2025 Annual Meeting of Stockholders."}],"balance_after":2725,"derivative":{"exercise_price":2.4,"expiration_date":"2034-08-19","underlying":"Common Stock","underlying_shares":2725},"source":{"system":"sec-edgar","filing":"0000950170-24-099838","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1007706/000095017024099838/ownership.xml","form_type":"4"}},{"id":1544021,"issuer":{"id":7071,"kind":"organization","name":"Rein Therapeutics, Inc."},"owners":[{"id":43624,"kind":"person","name":"VON RICKENBACH JOSEF H","position":1,"cik":"0001007706","reported_name":"VON RICKENBACH JOSEF H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-04-10T20:15:09.000Z","date":"2024-02-28","kind":"grant","planned":false,"acquired":true,"shares":2725,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on February 28, 2024. The shares underlying the option are scheduled to vest in full on the earlier of (i) February 28, 2025 or (ii) the date of the Issuer's 2024 Annual Meeting of Stockholders."}],"balance_after":2725,"derivative":{"exercise_price":4.72,"expiration_date":"2034-02-27","underlying":"Common Stock","underlying_shares":2725},"source":{"system":"sec-edgar","filing":"0000950170-24-043362","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1007706/000095017024043362/ownership.xml","form_type":"4/A","original_submission_date":"2024-03-01"}},{"id":1608251,"issuer":{"id":7071,"kind":"organization","name":"Rein Therapeutics, Inc."},"owners":[{"id":43624,"kind":"person","name":"VON RICKENBACH JOSEF H","position":1,"cik":"0001007706","reported_name":"VON RICKENBACH JOSEF H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-03-01T21:05:34.000Z","date":"2024-02-28","kind":"grant","planned":false,"acquired":true,"shares":2725,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on February 28, 2024. The shares underlying the option are scheduled to vest in full on the earlier of (i) February 28, 2025 or (ii) the date of the Issuer's 2024 Annual Meeting of Stockholders."}],"balance_after":2725,"derivative":{"exercise_price":4.8,"expiration_date":"2034-02-27","underlying":"Common Stock","underlying_shares":2725},"source":{"system":"sec-edgar","filing":"0000950170-24-023839","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1007706/000095017024023839/ownership.xml","form_type":"4"}},{"id":2228709,"issuer":{"id":7071,"kind":"organization","name":"Rein Therapeutics, Inc."},"owners":[{"id":43624,"kind":"person","name":"VON RICKENBACH JOSEF H","position":1,"cik":"0001007706","reported_name":"VON RICKENBACH JOSEF H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-06-17T21:16:13.000Z","date":"2022-06-15","kind":"grant","acquired":true,"shares":54500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on June 15, 2022. The shares underlying the option are scheduled to vest in full on the earlier of (i) June 15, 2023 or (ii) the date of the Issuer's 2023 Annual Meeting of Stockholders."}],"balance_after":54500,"derivative":{"exercise_price":0.397,"expiration_date":"2032-06-14","underlying":"Common Stock","underlying_shares":54500},"source":{"system":"sec-edgar","filing":"0000899243-22-023144","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1007706/000089924322023144/doc4.xml","form_type":"4"}},{"id":2454959,"issuer":{"id":114569,"kind":"organization","name":"Virgin Orbit Holdings, Inc.","symbol":"VORB"},"owners":[{"id":43624,"kind":"person","name":"VON RICKENBACH JOSEF H","position":1,"cik":"0001007706","reported_name":"VON RICKENBACH JOSEF H","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"FORMER DIRECTOR"}}],"security":"Common Stock","published_at":"2022-01-04T00:41:30.000Z","date":"2021-12-29","kind":"grant","acquired":true,"shares":125000,"price":10,"value":1250000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reflects Issuer's common stock acquired from the Issuer pursuant to a Subscription Agreement in connection with the business combination of NextGen Acquisition Corp. II (the former name of the Issuer) and Virgin Orbit Holdings, Inc. (formerly known as Virgin Orbit) (such business combination, the \"Business Combination\"), which closed on December 29, 2021. The reporting person resigned as a director of the Issuer upon consummation of the Business Combination."}],"balance_after":125000,"source":{"system":"sec-edgar","filing":"0001213900-22-000310","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1007706/000121390022000310/ownership.xml","form_type":"4"}},{"id":2664750,"issuer":{"id":7071,"kind":"organization","name":"Rein Therapeutics, Inc."},"owners":[{"id":43624,"kind":"person","name":"VON RICKENBACH JOSEF H","position":1,"cik":"0001007706","reported_name":"VON RICKENBACH JOSEF H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-06-17T23:51:43.000Z","date":"2021-06-15","kind":"grant","acquired":true,"shares":96000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on June 15, 2021. The shares underlying the option are scheduled to vest in full on the earlier of (i) June 15, 2022 or (ii) the date of the Issuer's 2022 Annual Meeting of Stockholders."}],"balance_after":96000,"derivative":{"exercise_price":1.29,"expiration_date":"2031-06-14","underlying":"Common Stock","underlying_shares":96000},"source":{"system":"sec-edgar","filing":"0000899243-21-024525","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1007706/000089924321024525/doc4.xml","form_type":"4"}},{"id":3105904,"issuer":{"id":7071,"kind":"organization","name":"Rein Therapeutics, Inc."},"owners":[{"id":43624,"kind":"person","name":"VON RICKENBACH JOSEF H","position":1,"cik":"0001007706","reported_name":"VON RICKENBACH JOSEF H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-06-18T20:33:13.000Z","date":"2020-06-17","kind":"grant","acquired":true,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on June 17, 2020. The shares underlying the option are scheduled to vest in full on the earlier of (i) June 17, 2021 or (ii) the date of the Issuer's 2021 Annual Meeting of Stockholders."}],"balance_after":12500,"derivative":{"exercise_price":1.15,"expiration_date":"2030-06-16","underlying":"Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0000899243-20-017085","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1007706/000089924320017085/doc4.xml","form_type":"4"}},{"id":3117387,"issuer":{"id":7071,"kind":"organization","name":"Rein Therapeutics, Inc."},"owners":[{"id":43624,"kind":"person","name":"VON RICKENBACH JOSEF H","position":1,"cik":"0001007706","reported_name":"VON RICKENBACH JOSEF H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-06-10T00:23:27.000Z","date":"2020-06-08","kind":"purchase","acquired":true,"shares":227272,"price":1.1,"value":249999.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects 227,272 shares that the were purchased by the Reporting Person directly from the underwriter in an underwritten public offering conducted by the Issuer."}],"balance_after":445460,"source":{"system":"sec-edgar","filing":"0000899243-20-015869","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1007706/000089924320015869/doc4.xml","form_type":"4"}},{"id":3414245,"issuer":{"id":7071,"kind":"organization","name":"Rein Therapeutics, Inc."},"owners":[{"id":43624,"kind":"person","name":"VON RICKENBACH JOSEF H","position":1,"cik":"0001007706","reported_name":"VON RICKENBACH JOSEF H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-09-16T20:55:46.000Z","date":"2019-09-13","kind":"purchase","acquired":true,"shares":25000,"price":0.9702,"value":24255.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.9360 per share to $0.99 per share, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":218188,"source":{"system":"sec-edgar","filing":"0000899243-19-023645","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1007706/000089924319023645/doc4.xml","form_type":"4"}},{"id":3414244,"issuer":{"id":7071,"kind":"organization","name":"Rein Therapeutics, Inc."},"owners":[{"id":43624,"kind":"person","name":"VON RICKENBACH JOSEF H","position":1,"cik":"0001007706","reported_name":"VON RICKENBACH JOSEF H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-09-16T20:55:46.000Z","date":"2019-09-12","kind":"purchase","acquired":true,"shares":88145,"price":0.9785,"value":86249.8825,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.8608 per share to $1.05 per share, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":193188,"source":{"system":"sec-edgar","filing":"0000899243-19-023645","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1007706/000089924319023645/doc4.xml","form_type":"4"}},{"id":3422355,"issuer":{"id":7071,"kind":"organization","name":"Rein Therapeutics, Inc."},"owners":[{"id":43624,"kind":"person","name":"VON RICKENBACH JOSEF H","position":1,"cik":"0001007706","reported_name":"VON RICKENBACH JOSEF H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-09-05T20:09:49.000Z","date":"2019-09-04","kind":"purchase","acquired":true,"shares":23225,"price":0.714,"value":16582.65,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.68 per share to $0.7486 per share, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":105043,"source":{"system":"sec-edgar","filing":"0000899243-19-022827","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1007706/000089924319022827/doc4.xml","form_type":"4"}},{"id":3423822,"issuer":{"id":7071,"kind":"organization","name":"Rein Therapeutics, Inc."},"owners":[{"id":43624,"kind":"person","name":"VON RICKENBACH JOSEF H","position":1,"cik":"0001007706","reported_name":"VON RICKENBACH JOSEF H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-09-04T20:14:46.000Z","date":"2019-09-03","kind":"purchase","acquired":true,"shares":13466,"price":0.7001,"value":9427.5466,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.6805 per share to $0.7204 per share, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":81818,"source":{"system":"sec-edgar","filing":"0000899243-19-022724","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1007706/000089924319022724/doc4.xml","form_type":"4"}},{"id":3423821,"issuer":{"id":7071,"kind":"organization","name":"Rein Therapeutics, Inc."},"owners":[{"id":43624,"kind":"person","name":"VON RICKENBACH JOSEF H","position":1,"cik":"0001007706","reported_name":"VON RICKENBACH JOSEF H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-09-04T20:14:46.000Z","date":"2019-08-30","kind":"purchase","acquired":true,"shares":15000,"price":0.7312,"value":10968.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.7155 per share to $0.75 per share, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":68352,"source":{"system":"sec-edgar","filing":"0000899243-19-022724","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1007706/000089924319022724/doc4.xml","form_type":"4"}},{"id":3425171,"issuer":{"id":7071,"kind":"organization","name":"Rein Therapeutics, Inc."},"owners":[{"id":43624,"kind":"person","name":"VON RICKENBACH JOSEF H","position":1,"cik":"0001007706","reported_name":"VON RICKENBACH JOSEF H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-09-03T21:17:19.000Z","date":"2019-08-29","kind":"purchase","acquired":true,"shares":3600,"price":0.7697,"value":2770.92,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.76 per share to $0.77 per share, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":53352,"source":{"system":"sec-edgar","filing":"0000899243-19-022676","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1007706/000089924319022676/doc4.xml","form_type":"4"}},{"id":3480437,"issuer":{"id":7071,"kind":"organization","name":"Rein Therapeutics, Inc."},"owners":[{"id":43624,"kind":"person","name":"VON RICKENBACH JOSEF H","position":1,"cik":"0001007706","reported_name":"VON RICKENBACH JOSEF H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-06-24T21:23:23.000Z","date":"2019-06-19","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on June 19, 2019. The shares underlying the option are scheduled to vest in equal annual installments over three years from June 19, 2019."}],"balance_after":25000,"derivative":{"exercise_price":0.86,"expiration_date":"2029-06-18","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0000899243-19-017968","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1007706/000089924319017968/doc4.xml","form_type":"4"}},{"id":4193030,"issuer":{"id":172709,"kind":"organization","name":"PAREXEL INTERNATIONAL CORP","symbol":"PRXL"},"owners":[{"id":43624,"kind":"person","name":"VON RICKENBACH JOSEF H","position":1,"cik":"0001007706","reported_name":"VON RICKENBACH JOSEF H","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Restricted Stock Units","published_at":"2017-10-04T20:07:36.000Z","date":"2017-09-29","kind":"other","acquired":false,"shares":9000,"price":88.1,"value":792900.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F9","text":"Pursuant to the terms of the Merger Agreement, immediately prior to the Effective Time, each Company RSU Award, whether or not vested, was assumed by West Street Parent, LLC or the Company, cancelled and exchanged for the right to receive an amount in cash equal to the product obtained by multiplying (i) the aggregate number of shares of Company Common Stock subject to such award by (ii) the Merger Consideration."}],"balance_after":0,"derivative":{"exercise_price":0,"exercise_date":"2016-09-09","expiration_date":"2017-12-31","underlying":"Common Stock","underlying_shares":9000},"source":{"system":"sec-edgar","filing":"0000899243-17-023611","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/799729/000089924317023611/doc4.xml","form_type":"4"}},{"id":4193029,"issuer":{"id":172709,"kind":"organization","name":"PAREXEL INTERNATIONAL CORP","symbol":"PRXL"},"owners":[{"id":43624,"kind":"person","name":"VON RICKENBACH JOSEF H","position":1,"cik":"0001007706","reported_name":"VON RICKENBACH JOSEF H","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Restricted Stock Units","published_at":"2017-10-04T20:07:36.000Z","date":"2017-09-29","kind":"other","acquired":true,"shares":5700,"price":88.1,"value":502170.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F9","text":"Pursuant to the terms of the Merger Agreement, immediately prior to the Effective Time, each Company RSU Award, whether or not vested, was assumed by West Street Parent, LLC or the Company, cancelled and exchanged for the right to receive an amount in cash equal to the product obtained by multiplying (i) the aggregate number of shares of Company Common Stock subject to such award by (ii) the Merger Consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F12","text":"These restricted stock units were to vest in full on 09/09/2018."}],"balance_after":9000,"derivative":{"exercise_price":0,"expiration_date":"2018-12-31","underlying":"Common Stock","underlying_shares":5700},"source":{"system":"sec-edgar","filing":"0000899243-17-023611","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/799729/000089924317023611/doc4.xml","form_type":"4"}},{"id":4193028,"issuer":{"id":172709,"kind":"organization","name":"PAREXEL INTERNATIONAL CORP","symbol":"PRXL"},"owners":[{"id":43624,"kind":"person","name":"VON RICKENBACH JOSEF H","position":1,"cik":"0001007706","reported_name":"VON RICKENBACH JOSEF H","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Restricted Stock Units","published_at":"2017-10-04T20:07:36.000Z","date":"2017-09-29","kind":"other","acquired":false,"shares":21015,"price":88.1,"value":1851421.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F9","text":"Pursuant to the terms of the Merger Agreement, immediately prior to the Effective Time, each Company RSU Award, whether or not vested, was assumed by West Street Parent, LLC or the Company, cancelled and exchanged for the right to receive an amount in cash equal to the product obtained by multiplying (i) the aggregate number of shares of Company Common Stock subject to such award by (ii) the Merger Consideration."}],"balance_after":0,"derivative":{"exercise_price":0,"exercise_date":"2016-09-09","expiration_date":"2017-12-31","underlying":"Common Stock","underlying_shares":21015},"source":{"system":"sec-edgar","filing":"0000899243-17-023611","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/799729/000089924317023611/doc4.xml","form_type":"4"}},{"id":4193027,"issuer":{"id":172709,"kind":"organization","name":"PAREXEL INTERNATIONAL CORP","symbol":"PRXL"},"owners":[{"id":43624,"kind":"person","name":"VON RICKENBACH JOSEF H","position":1,"cik":"0001007706","reported_name":"VON RICKENBACH JOSEF H","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Restricted Stock Units","published_at":"2017-10-04T20:07:36.000Z","date":"2017-09-29","kind":"other","acquired":true,"shares":15960,"price":88.1,"value":1406076.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F9","text":"Pursuant to the terms of the Merger Agreement, immediately prior to the Effective Time, each Company RSU Award, whether or not vested, was assumed by West Street Parent, LLC or the Company, cancelled and exchanged for the right to receive an amount in cash equal to the product obtained by multiplying (i) the aggregate number of shares of Company Common Stock subject to such award by (ii) the Merger Consideration."}],"balance_after":21015,"derivative":{"exercise_price":0,"exercise_date":"2016-09-09","expiration_date":"2017-12-31","underlying":"Common Stock","underlying_shares":15960},"source":{"system":"sec-edgar","filing":"0000899243-17-023611","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/799729/000089924317023611/doc4.xml","form_type":"4"}},{"id":4193026,"issuer":{"id":172709,"kind":"organization","name":"PAREXEL INTERNATIONAL CORP","symbol":"PRXL"},"owners":[{"id":43624,"kind":"person","name":"VON RICKENBACH JOSEF H","position":1,"cik":"0001007706","reported_name":"VON RICKENBACH JOSEF H","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Restricted Stock Units","published_at":"2017-10-04T20:07:36.000Z","date":"2017-09-29","kind":"other","acquired":false,"shares":14800,"price":88.1,"value":1303880.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F9","text":"Pursuant to the terms of the Merger Agreement, immediately prior to the Effective Time, each Company RSU Award, whether or not vested, was assumed by West Street Parent, LLC or the Company, cancelled and exchanged for the right to receive an amount in cash equal to the product obtained by multiplying (i) the aggregate number of shares of Company Common Stock subject to such award by (ii) the Merger Consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F10","text":"These restricted stock units were to vest in full on September 9, 2018."}],"balance_after":0,"derivative":{"exercise_price":0,"expiration_date":"2018-12-31","underlying":"Common Stock","underlying_shares":14800},"source":{"system":"sec-edgar","filing":"0000899243-17-023611","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/799729/000089924317023611/doc4.xml","form_type":"4"}},{"id":4193025,"issuer":{"id":172709,"kind":"organization","name":"PAREXEL INTERNATIONAL CORP","symbol":"PRXL"},"owners":[{"id":43624,"kind":"person","name":"VON RICKENBACH JOSEF H","position":1,"cik":"0001007706","reported_name":"VON RICKENBACH JOSEF H","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Restricted Stock Units","published_at":"2017-10-04T20:07:36.000Z","date":"2017-09-29","kind":"other","acquired":true,"shares":11988,"price":88.1,"value":1056142.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F9","text":"Pursuant to the terms of the Merger Agreement, immediately prior to the Effective Time, each Company RSU Award, whether or not vested, was assumed by West Street Parent, LLC or the Company, cancelled and exchanged for the right to receive an amount in cash equal to the product obtained by multiplying (i) the aggregate number of shares of Company Common Stock subject to such award by (ii) the Merger Consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F11","text":"These restricted stock units were to vest in full on 09/14/2019."}],"balance_after":14800,"derivative":{"exercise_price":0,"expiration_date":"2017-12-31","underlying":"Common Stock","underlying_shares":11988},"source":{"system":"sec-edgar","filing":"0000899243-17-023611","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/799729/000089924317023611/doc4.xml","form_type":"4"}},{"id":4193024,"issuer":{"id":172709,"kind":"organization","name":"PAREXEL INTERNATIONAL CORP","symbol":"PRXL"},"owners":[{"id":43624,"kind":"person","name":"VON RICKENBACH JOSEF H","position":1,"cik":"0001007706","reported_name":"VON RICKENBACH JOSEF H","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Restricted Stock Units","published_at":"2017-10-04T20:07:36.000Z","date":"2017-09-29","kind":"other","acquired":false,"shares":29600,"price":88.1,"value":2607760.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F9","text":"Pursuant to the terms of the Merger Agreement, immediately prior to the Effective Time, each Company RSU Award, whether or not vested, was assumed by West Street Parent, LLC or the Company, cancelled and exchanged for the right to receive an amount in cash equal to the product obtained by multiplying (i) the aggregate number of shares of Company Common Stock subject to such award by (ii) the Merger Consideration."}],"balance_after":0,"derivative":{"exercise_price":0,"exercise_date":"2017-09-10","expiration_date":"2017-12-31","underlying":"Common Stock","underlying_shares":29600},"source":{"system":"sec-edgar","filing":"0000899243-17-023611","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/799729/000089924317023611/doc4.xml","form_type":"4"}},{"id":4193023,"issuer":{"id":172709,"kind":"organization","name":"PAREXEL INTERNATIONAL CORP","symbol":"PRXL"},"owners":[{"id":43624,"kind":"person","name":"VON RICKENBACH JOSEF H","position":1,"cik":"0001007706","reported_name":"VON RICKENBACH JOSEF H","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Restricted Stock Units","published_at":"2017-10-04T20:07:36.000Z","date":"2017-09-29","kind":"other","acquired":true,"shares":29600,"price":88.1,"value":2607760.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F9","text":"Pursuant to the terms of the Merger Agreement, immediately prior to the Effective Time, each Company RSU Award, whether or not vested, was assumed by West Street Parent, LLC or the Company, cancelled and exchanged for the right to receive an amount in cash equal to the product obtained by multiplying (i) the aggregate number of shares of Company Common Stock subject to such award by (ii) the Merger Consideration."}],"balance_after":29600,"derivative":{"exercise_price":0,"exercise_date":"2017-09-10","expiration_date":"2017-12-31","underlying":"Common Stock","underlying_shares":29600},"source":{"system":"sec-edgar","filing":"0000899243-17-023611","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/799729/000089924317023611/doc4.xml","form_type":"4"}},{"id":4193022,"issuer":{"id":172709,"kind":"organization","name":"PAREXEL INTERNATIONAL CORP","symbol":"PRXL"},"owners":[{"id":43624,"kind":"person","name":"VON RICKENBACH JOSEF H","position":1,"cik":"0001007706","reported_name":"VON RICKENBACH JOSEF H","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Stock Options (Right to Buy)","published_at":"2017-10-04T20:07:36.000Z","date":"2017-09-29","kind":"other","acquired":false,"shares":151700,"price":67.84,"value":10291328.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Pursuant to the terms of the Agreement and Plan of Merger by and among PAREXEL International Corporation, West Street Parent, LLC and West Street Merger Sub, Inc., dated June 19, 2017, each Company Stock Option, whether or not vested or exercisable, automatically converted into the right to receive an amount in cash equal to the product obtained by multiplying (i) the excess of the Merger Consideration over the per share exercise price of such Company Stock Option, by (ii) the aggregate number of shares of Company Common Stock issuable upon exercise of settlement of such Company Stock Option prior to the Effective Time."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"Options become exercisable in increments of 25% of the total shares granted, which commenced on the first anniversary of 09/21/2011."}],"balance_after":0,"derivative":{"exercise_price":20.26,"expiration_date":"2019-09-21","underlying":"Common Stock","underlying_shares":151700},"source":{"system":"sec-edgar","filing":"0000899243-17-023611","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/799729/000089924317023611/doc4.xml","form_type":"4"}},{"id":4193021,"issuer":{"id":172709,"kind":"organization","name":"PAREXEL INTERNATIONAL CORP","symbol":"PRXL"},"owners":[{"id":43624,"kind":"person","name":"VON RICKENBACH JOSEF H","position":1,"cik":"0001007706","reported_name":"VON RICKENBACH JOSEF H","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Stock Options (Right to Buy)","published_at":"2017-10-04T20:07:36.000Z","date":"2017-09-29","kind":"other","acquired":false,"shares":108800,"price":57.46,"value":6251648.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Pursuant to the terms of the Agreement and Plan of Merger by and among PAREXEL International Corporation, West Street Parent, LLC and West Street Merger Sub, Inc., dated June 19, 2017, each Company Stock Option, whether or not vested or exercisable, automatically converted into the right to receive an amount in cash equal to the product obtained by multiplying (i) the excess of the Merger Consideration over the per share exercise price of such Company Stock Option, by (ii) the aggregate number of shares of Company Common Stock issuable upon exercise of settlement of such Company Stock Option prior to the Effective Time."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Options become exercisable in increments of 25% of the total shares granted, which commenced on the first anniversary of 09/19/2012."}],"balance_after":0,"derivative":{"exercise_price":30.64,"expiration_date":"2020-09-19","underlying":"Common Stock","underlying_shares":108800},"source":{"system":"sec-edgar","filing":"0000899243-17-023611","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/799729/000089924317023611/doc4.xml","form_type":"4"}},{"id":4193020,"issuer":{"id":172709,"kind":"organization","name":"PAREXEL INTERNATIONAL CORP","symbol":"PRXL"},"owners":[{"id":43624,"kind":"person","name":"VON RICKENBACH JOSEF H","position":1,"cik":"0001007706","reported_name":"VON RICKENBACH JOSEF H","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Stock Options (Right to Buy)","published_at":"2017-10-04T20:07:36.000Z","date":"2017-09-29","kind":"other","acquired":false,"shares":73500,"price":39.41,"value":2896635.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Pursuant to the terms of the Agreement and Plan of Merger by and among PAREXEL International Corporation, West Street Parent, LLC and West Street Merger Sub, Inc., dated June 19, 2017, each Company Stock Option, whether or not vested or exercisable, automatically converted into the right to receive an amount in cash equal to the product obtained by multiplying (i) the excess of the Merger Consideration over the per share exercise price of such Company Stock Option, by (ii) the aggregate number of shares of Company Common Stock issuable upon exercise of settlement of such Company Stock Option prior to the Effective Time."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Options become exercisable in increments of 25% of the total shares granted, which commenced on the first anniversary of 09/11/2013."}],"balance_after":0,"derivative":{"exercise_price":48.69,"expiration_date":"2021-09-11","underlying":"Common Stock","underlying_shares":73500},"source":{"system":"sec-edgar","filing":"0000899243-17-023611","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/799729/000089924317023611/doc4.xml","form_type":"4"}},{"id":4193019,"issuer":{"id":172709,"kind":"organization","name":"PAREXEL INTERNATIONAL CORP","symbol":"PRXL"},"owners":[{"id":43624,"kind":"person","name":"VON RICKENBACH JOSEF H","position":1,"cik":"0001007706","reported_name":"VON RICKENBACH JOSEF H","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Stock Options (Right to Buy)","published_at":"2017-10-04T20:07:36.000Z","date":"2017-09-29","kind":"other","acquired":false,"shares":93300,"price":30.17,"value":2814861.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Pursuant to the terms of the Agreement and Plan of Merger by and among PAREXEL International Corporation, West Street Parent, LLC and West Street Merger Sub, Inc., dated June 19, 2017, each Company Stock Option, whether or not vested or exercisable, automatically converted into the right to receive an amount in cash equal to the product obtained by multiplying (i) the excess of the Merger Consideration over the per share exercise price of such Company Stock Option, by (ii) the aggregate number of shares of Company Common Stock issuable upon exercise of settlement of such Company Stock Option prior to the Effective Time."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Options become exercisable in increments of 25% of the total shares granted, which commenced on the first anniversary of 09/10/2014."}],"balance_after":0,"derivative":{"exercise_price":57.93,"expiration_date":"2022-09-10","underlying":"Common Stock","underlying_shares":93300},"source":{"system":"sec-edgar","filing":"0000899243-17-023611","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/799729/000089924317023611/doc4.xml","form_type":"4"}},{"id":4193018,"issuer":{"id":172709,"kind":"organization","name":"PAREXEL INTERNATIONAL CORP","symbol":"PRXL"},"owners":[{"id":43624,"kind":"person","name":"VON RICKENBACH JOSEF H","position":1,"cik":"0001007706","reported_name":"VON RICKENBACH JOSEF H","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Stock Options (Right to Buy)","published_at":"2017-10-04T20:07:36.000Z","date":"2017-09-29","kind":"other","acquired":false,"shares":95000,"price":21.52,"value":2044400.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Pursuant to the terms of the Agreement and Plan of Merger by and among PAREXEL International Corporation, West Street Parent, LLC and West Street Merger Sub, Inc., dated June 19, 2017, each Company Stock Option, whether or not vested or exercisable, automatically converted into the right to receive an amount in cash equal to the product obtained by multiplying (i) the excess of the Merger Consideration over the per share exercise price of such Company Stock Option, by (ii) the aggregate number of shares of Company Common Stock issuable upon exercise of settlement of such Company Stock Option prior to the Effective Time."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Options become exercisable in increments of 25% of the total shares granted, which commenced on the first anniversary of 09/09/2015."}],"balance_after":0,"derivative":{"exercise_price":66.58,"expiration_date":"2023-09-09","underlying":"Common Stock","underlying_shares":95000},"source":{"system":"sec-edgar","filing":"0000899243-17-023611","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/799729/000089924317023611/doc4.xml","form_type":"4"}},{"id":4193017,"issuer":{"id":172709,"kind":"organization","name":"PAREXEL INTERNATIONAL CORP","symbol":"PRXL"},"owners":[{"id":43624,"kind":"person","name":"VON RICKENBACH JOSEF H","position":1,"cik":"0001007706","reported_name":"VON RICKENBACH JOSEF H","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Stock Options (Right to Buy)","published_at":"2017-10-04T20:07:36.000Z","date":"2017-09-29","kind":"other","acquired":false,"shares":50800,"price":21.1,"value":1071880.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Pursuant to the terms of the Agreement and Plan of Merger by and among PAREXEL International Corporation, West Street Parent, LLC and West Street Merger Sub, Inc., dated June 19, 2017, each Company Stock Option, whether or not vested or exercisable, automatically converted into the right to receive an amount in cash equal to the product obtained by multiplying (i) the excess of the Merger Consideration over the per share exercise price of such Company Stock Option, by (ii) the aggregate number of shares of Company Common Stock issuable upon exercise of settlement of such Company Stock Option prior to the Effective Time."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Options become exercisable in increments of 25% of the total shares granted, which commenced on the first anniversary of 09/14/2016."}],"balance_after":0,"derivative":{"exercise_price":67,"expiration_date":"2024-09-14","underlying":"Common Stock","underlying_shares":50800},"source":{"system":"sec-edgar","filing":"0000899243-17-023611","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/799729/000089924317023611/doc4.xml","form_type":"4"}},{"id":4193016,"issuer":{"id":172709,"kind":"organization","name":"PAREXEL INTERNATIONAL CORP","symbol":"PRXL"},"owners":[{"id":43624,"kind":"person","name":"VON RICKENBACH JOSEF H","position":1,"cik":"0001007706","reported_name":"VON RICKENBACH JOSEF H","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chairman & CEO"}}],"security":"Common Stock","published_at":"2017-10-04T20:07:36.000Z","date":"2017-09-29","kind":"disposition_to_issuer","acquired":false,"shares":503329,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposed of pursuant to the Agreement and Plan of Merger by and among PAREXEL International Corporation, West Street Parent, LLC and West Street Merger Sub, Inc., dated June 19, 2017 (the \"Merger Agreement\"), whereby, at the effective time of the merger contemplated therein (the \"Effective Time\"), all issued and outstanding shares of the Issuer's common stock were automatically cancelled and converted into the right to receive $88.10 per share in cash without interest (the \"Merger Consideration\")."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Disposed of pursuant to the Agreement and Plan of Merger by and among PAREXEL International Corporation, West Street Parent, LLC and West Street Merger Sub, Inc., dated June 19, 2017 (the \"Merger Agreement\"), whereby, at the effective time of the merger contemplated therein (the \"Effective Time\"), all issued and outstanding shares of the Issuer's common stock were automatically cancelled and converted into the right to receive $88.10 per share in cash without interest (the \"Merger Consideration\")."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-17-023611","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/799729/000089924317023611/doc4.xml","form_type":"4"}},{"id":4207713,"issuer":{"id":172709,"kind":"organization","name":"PAREXEL INTERNATIONAL CORP","symbol":"PRXL"},"owners":[{"id":43624,"kind":"person","name":"VON RICKENBACH JOSEF H","position":1,"cik":"0001007706","reported_name":"VON RICKENBACH JOSEF H","relationship":{"director":true,"officer":true,"officer_title":"Chairman & CEO"}}],"security":"Common Stock","published_at":"2017-09-18T12:07:11.000Z","date":"2017-09-14","kind":"tax_withholding","acquired":false,"shares":4642,"price":87.93,"value":408171.06,"ownership":{"direct":true},"balance_after":503329,"source":{"system":"sec-edgar","filing":"0001127602-17-027561","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/799729/000112760217027561/form4.xml","form_type":"4"}},{"id":4212202,"issuer":{"id":172709,"kind":"organization","name":"PAREXEL INTERNATIONAL CORP","symbol":"PRXL"},"owners":[{"id":43624,"kind":"person","name":"VON RICKENBACH JOSEF H","position":1,"cik":"0001007706","reported_name":"VON RICKENBACH JOSEF H","relationship":{"director":true,"officer":true,"officer_title":"Chairman & CEO"}}],"security":"Restricted Stock Units","published_at":"2017-09-12T13:15:31.000Z","date":"2017-09-10","kind":"exercise","acquired":false,"shares":9308,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of PAREXEL International Corporation common stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units awarded pursuant to the PAREXEL International Corporation 2010 Stock Incentive Plan will vest in full on September 10, 2017.  Vested shares will be delivered to the reporting person as soon as practicable following the vesting date, and in any event no later than December 31, 2017."}],"balance_after":0,"derivative":{"exercise_date":"2017-09-10","underlying":"Common Stock","underlying_shares":9308},"source":{"system":"sec-edgar","filing":"0001127602-17-027310","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/799729/000112760217027310/form4.xml","form_type":"4"}},{"id":4212201,"issuer":{"id":172709,"kind":"organization","name":"PAREXEL INTERNATIONAL CORP","symbol":"PRXL"},"owners":[{"id":43624,"kind":"person","name":"VON RICKENBACH JOSEF H","position":1,"cik":"0001007706","reported_name":"VON RICKENBACH JOSEF H","relationship":{"director":true,"officer":true,"officer_title":"Chairman & CEO"}}],"security":"Restricted Stock Units","published_at":"2017-09-12T13:15:31.000Z","date":"2017-09-08","kind":"grant","acquired":true,"shares":2812,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of PAREXEL International Corporation common stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"These restricted stock units awarded pursuant to the PAREXEL International Corporation 2015 Stock Incentive Plan will vest in full on September 14, 2019 subject to the satisfaction of certain performance criteria.  Vested shares will be delivered to the reporting person as soon as practicable following the vesting date, and in any event no later than December 31, 2019."}],"balance_after":2812,"derivative":{"exercise_date":"2019-09-14","underlying":"Common Stock","underlying_shares":2812},"source":{"system":"sec-edgar","filing":"0001127602-17-027310","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/799729/000112760217027310/form4.xml","form_type":"4"}},{"id":4212200,"issuer":{"id":172709,"kind":"organization","name":"PAREXEL INTERNATIONAL CORP","symbol":"PRXL"},"owners":[{"id":43624,"kind":"person","name":"VON RICKENBACH JOSEF H","position":1,"cik":"0001007706","reported_name":"VON RICKENBACH JOSEF H","relationship":{"director":true,"officer":true,"officer_title":"Chairman & CEO"}}],"security":"Restricted Stock Units","published_at":"2017-09-12T13:15:31.000Z","date":"2017-09-08","kind":"grant","acquired":true,"shares":1755,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of PAREXEL International Corporation common stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The restricted stock units awarded pursuant to the PAREXEL International Corporation Stock Incentive Plans will vest in full on September 9, 2018.  Vested shares will be delivered to the reporting person as soon as practicable following the vesting date, and in any event no later than December 31, 2018."}],"balance_after":5055,"derivative":{"exercise_date":"2018-09-09","underlying":"Common Stock","underlying_shares":1755},"source":{"system":"sec-edgar","filing":"0001127602-17-027310","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/799729/000112760217027310/form4.xml","form_type":"4"}},{"id":4212199,"issuer":{"id":172709,"kind":"organization","name":"PAREXEL INTERNATIONAL CORP","symbol":"PRXL"},"owners":[{"id":43624,"kind":"person","name":"VON RICKENBACH JOSEF H","position":1,"cik":"0001007706","reported_name":"VON RICKENBACH JOSEF H","relationship":{"director":true,"officer":true,"officer_title":"Chairman & CEO"}}],"security":"Restricted Stock Units","published_at":"2017-09-12T13:15:31.000Z","date":"2017-09-08","kind":"grant","acquired":true,"shares":2028,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of PAREXEL International Corporation common stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units awarded pursuant to the PAREXEL International Corporation 2010 Stock Incentive Plan will vest in full on September 10, 2017.  Vested shares will be delivered to the reporting person as soon as practicable following the vesting date, and in any event no later than December 31, 2017."}],"balance_after":9308,"derivative":{"exercise_date":"2017-09-10","underlying":"Common Stock","underlying_shares":2028},"source":{"system":"sec-edgar","filing":"0001127602-17-027310","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/799729/000112760217027310/form4.xml","form_type":"4"}},{"id":4212198,"issuer":{"id":172709,"kind":"organization","name":"PAREXEL INTERNATIONAL CORP","symbol":"PRXL"},"owners":[{"id":43624,"kind":"person","name":"VON RICKENBACH JOSEF H","position":1,"cik":"0001007706","reported_name":"VON RICKENBACH JOSEF H","relationship":{"director":true,"officer":true,"officer_title":"Chairman & CEO"}}],"security":"Common Stock","published_at":"2017-09-12T13:15:31.000Z","date":"2017-09-11","kind":"tax_withholding","acquired":false,"shares":15402,"price":87.77,"value":1351833.54,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 507 shares of common stock acquired pursuant to the Issuer's 2000 Employee Stock Purchase Plan."}],"balance_after":507971,"source":{"system":"sec-edgar","filing":"0001127602-17-027310","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/799729/000112760217027310/form4.xml","form_type":"4"}},{"id":4212197,"issuer":{"id":172709,"kind":"organization","name":"PAREXEL INTERNATIONAL CORP","symbol":"PRXL"},"owners":[{"id":43624,"kind":"person","name":"VON RICKENBACH JOSEF H","position":1,"cik":"0001007706","reported_name":"VON RICKENBACH JOSEF H","relationship":{"director":true,"officer":true,"officer_title":"Chairman & CEO"}}],"security":"Common Stock","published_at":"2017-09-12T13:15:31.000Z","date":"2017-09-10","kind":"exercise","acquired":true,"shares":9308,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":523373,"source":{"system":"sec-edgar","filing":"0001127602-17-027310","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/799729/000112760217027310/form4.xml","form_type":"4"}},{"id":4212196,"issuer":{"id":172709,"kind":"organization","name":"PAREXEL INTERNATIONAL CORP","symbol":"PRXL"},"owners":[{"id":43624,"kind":"person","name":"VON RICKENBACH JOSEF H","position":1,"cik":"0001007706","reported_name":"VON RICKENBACH JOSEF H","relationship":{"director":true,"officer":true,"officer_title":"Chairman & CEO"}}],"security":"Common Stock","published_at":"2017-09-12T13:15:31.000Z","date":"2017-09-08","kind":"gift","acquired":false,"shares":22795,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":514065,"source":{"system":"sec-edgar","filing":"0001127602-17-027310","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/799729/000112760217027310/form4.xml","form_type":"4"}},{"id":4602125,"issuer":{"id":172709,"kind":"organization","name":"PAREXEL INTERNATIONAL CORP","symbol":"PRXL"},"owners":[{"id":43624,"kind":"person","name":"VON RICKENBACH JOSEF H","position":1,"cik":"0001007706","reported_name":"VON RICKENBACH JOSEF H","relationship":{"director":true,"officer":true,"officer_title":"Chairman & CEO"}}],"security":"Restricted Stock Units","published_at":"2016-09-16T16:08:58.000Z","date":"2016-09-14","kind":"grant","acquired":true,"shares":3300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of PAREXEL International Corporation common stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The restricted stock units awarded pursuant to the PAREXEL International Corporation Stock Incentive Plans will vest in full on September 9, 2018.  Vested shares will be delivered to the reporting person as soon as practicable following the vesting date, and in any event no later than December 31, 2018."}],"balance_after":3300,"derivative":{"exercise_date":"2018-09-09","underlying":"Common Stock","underlying_shares":3300},"source":{"system":"sec-edgar","filing":"0001127602-16-062666","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/799729/000112760216062666/form4.xml","form_type":"4"}},{"id":4602124,"issuer":{"id":172709,"kind":"organization","name":"PAREXEL INTERNATIONAL CORP","symbol":"PRXL"},"owners":[{"id":43624,"kind":"person","name":"VON RICKENBACH JOSEF H","position":1,"cik":"0001007706","reported_name":"VON RICKENBACH JOSEF H","relationship":{"director":true,"officer":true,"officer_title":"Chairman & CEO"}}],"security":"Restricted Stock Units","published_at":"2016-09-16T16:08:58.000Z","date":"2016-09-14","kind":"grant","acquired":true,"shares":4420,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of PAREXEL International Corporation common stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The restricted stock units awarded pursuant to the PAREXEL International Corporation 2010 Stock Incentive Plan will vest in full on September 10, 2017.  Vested shares will be delivered to the reporting person as soon as practicable following the vesting date, and in any event no later than December 31, 2017."}],"balance_after":7280,"derivative":{"exercise_date":"2017-09-10","underlying":"Common Stock","underlying_shares":4420},"source":{"system":"sec-edgar","filing":"0001127602-16-062666","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/799729/000112760216062666/form4.xml","form_type":"4"}},{"id":4602123,"issuer":{"id":172709,"kind":"organization","name":"PAREXEL INTERNATIONAL CORP","symbol":"PRXL"},"owners":[{"id":43624,"kind":"person","name":"VON RICKENBACH JOSEF H","position":1,"cik":"0001007706","reported_name":"VON RICKENBACH JOSEF H","relationship":{"director":true,"officer":true,"officer_title":"Chairman & CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2016-09-16T16:08:58.000Z","date":"2016-09-14","kind":"grant","acquired":true,"shares":50800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Options become exercisable in increments of 25% of the total shares granted commencing on the first anniversary of the date of grant."}],"balance_after":50800,"derivative":{"exercise_price":67,"expiration_date":"2024-09-14","underlying":"Common Stock","underlying_shares":50800},"source":{"system":"sec-edgar","filing":"0001127602-16-062666","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/799729/000112760216062666/form4.xml","form_type":"4"}},{"id":4602122,"issuer":{"id":172709,"kind":"organization","name":"PAREXEL INTERNATIONAL CORP","symbol":"PRXL"},"owners":[{"id":43624,"kind":"person","name":"VON RICKENBACH JOSEF H","position":1,"cik":"0001007706","reported_name":"VON RICKENBACH JOSEF H","relationship":{"director":true,"officer":true,"officer_title":"Chairman & CEO"}}],"security":"Common Stock","published_at":"2016-09-16T16:08:58.000Z","date":"2016-09-14","kind":"grant","acquired":true,"shares":29600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Shares of restricted stock awarded pursuant to  PAREXEL International Corporation 2015 Stock Incentive Plan."}],"balance_after":536353,"source":{"system":"sec-edgar","filing":"0001127602-16-062666","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/799729/000112760216062666/form4.xml","form_type":"4"}},{"id":4603678,"issuer":{"id":172709,"kind":"organization","name":"PAREXEL INTERNATIONAL CORP","symbol":"PRXL"},"owners":[{"id":43624,"kind":"person","name":"VON RICKENBACH JOSEF H","position":1,"cik":"0001007706","reported_name":"VON RICKENBACH JOSEF H","relationship":{"director":true,"officer":true,"officer_title":"Chairman & CEO"}}],"security":"Common Stock","published_at":"2016-09-14T09:35:38.000Z","date":"2016-09-12","kind":"tax_withholding","acquired":false,"shares":14743,"price":66.54,"value":980999.22,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 366 shares of common stock acquired pursuant to the Issuer's 2000 Employee Stock Purchase Plan."}],"balance_after":506753,"source":{"system":"sec-edgar","filing":"0001127602-16-062490","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/799729/000112760216062490/form4.xml","form_type":"4"}}]}